Results 191 to 200 of about 1,195,397 (240)
Objectives Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition, with widely varying global prevalence estimates. Frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the US or UK at 19‐39 per 100,000 as opposed to 65‐97 per 100,000.
Lucinda Roper +7 more
wiley +1 more source
Study on the potential links between clinical features of oral lichenoid mucositis and systemic diseases. [PDF]
Wang P +10 more
europepmc +1 more source
Association between pulp stones and systemic diseases: a retrospective study using digital panoramic radiographs in a Turkish population. [PDF]
Beytaş Alğan B +3 more
europepmc +1 more source
Introduction Rheumatic and musculoskeletal diseases(RMDs) are leading causes of physical disability, necessitating support with activities of daily living(ADLs). This study describes social care received by patients with RMDs in two disperate regions of England: Salford(urban) and Norfolk(rural).
Mehreen Somro +6 more
wiley +1 more source
The role of salivary metabolomics in chronic periodontitis: bridging oral and systemic diseases. [PDF]
Albahri J +3 more
europepmc +1 more source
Objective We aimed to estimate the prevalence and cumulative incidence of hydroxychloroquine retinopathy (HCQ‐R) and its risk factors among long‐term HCQ users with rheumatic diseases through a systematic review and meta‐analysis of observational studies that used spectral‐domain OCT (SD‐OCT) for screening. Methods A systematic search of PubMed, Scopus,
Narsis Daftarian +4 more
wiley +1 more source
Investigating the link between oral health conditions and systemic diseases: A cross-sectional analysis. [PDF]
Natarajan P, Madanian S, Marshall S.
europepmc +1 more source
Background Clinical response to Mycophenolic acid (MPA) is highly heterogeneous; thus, therapeutic drug monitoring (TDM) may help improve treatment efficacy. This systematic review and meta‐analysis examined therapeutic ranges for MPA levels associated with better outcomes and safety in patients with SLE, particularly those with extra‐renal ...
Zahraa Qamhieh +5 more
wiley +1 more source
Salzmann Nodular Degeneration in Ocular and Systemic Diseases. [PDF]
Roszkowska AM +6 more
europepmc +1 more source
Objective We aimed to construct and evaluate the first laboratory‐based frailty index (FI‐Lab) for predicting adverse outcomes in systemic lupus erythematosus (SLE) and to compare its predictive ability to that of an existing clinical frailty index (FI).
Grace Burns +2 more
wiley +1 more source

